-
IGF2BP1–THBS1 Axis in Pulmonary Fibrosis
2026-09-15
A 2025 study identifies an m6A-dependent IGF2BP1–THBS1–TLR4 pathway that links macrophage glycolytic reprogramming with profibrotic polarization in pulmonary fibrosis. Its knockdown and rescue experiments provide a mechanistic framework for studying how RNA stability and macrophage metabolism influence fibrotic lung injury.
-
Chloroquine: Itch, Autophagy, and Assay Workflows
2026-09-15
Chloroquine is more than an autophagy inhibitor: it is a practical probe for lysosomal biology, immune signaling, and MrgprA3-dependent itch. This workflow-focused guide shows how to use it in dermatitis, cancer, antiviral, malaria, and rheumatoid arthritis research while controlling for pleiotropic effects and assay artifacts.
-
Stiripentol: From LDH Assay to Translational Insight
2026-09-14
Stiripentol is an LDH inhibitor that enables a more rigorous study of lactate flux, seizure biology, and metabolic-epigenetic signaling. This article translates recent MPC–lactate findings into practical assay decisions while distinguishing established evidence from testable hypotheses.
-
GW 6471: A Causal Probe for PPARα Biology
2026-09-14
A translational framework for using GW 6471 to test whether PPARα activity causally links environmental exposure to lipid dysregulation, liver injury, and metabolic phenotypes.
-
Firefly Luciferase mRNA for Delivery Assay Design
2026-09-13
Firefly Luciferase mRNA can do more than report gene expression: it can help dissect how mRNA chemistry, delivery vehicles, and cell state shape translation. This guide uses 5-moUTP chemistry and recent Pickering-emulsion findings to develop more interpretable delivery and translation efficiency assays.
-
RSAD2 at the SLE Maternal-Fetal Interface
2026-09-12
Ding et al. identify RSAD2 as a pathogenic interferon-stimulated gene at the maternal-fetal interface in systemic lupus erythematosus, linking excessive type I interferon activity to placental lipid accumulation and impaired vasculogenesis. The study combines human tissue analysis, Rsad2 depletion, disease-relevant mouse models, and L-chicoric acid intervention to connect mechanism with potential therapeutic direction.
-
How Mixing Shapes mRNA LNP Performance
2026-09-12
A Nature Communications study isolates primary mixing as a major determinant of mRNA lipid nanoparticle physicochemistry and biological performance. By comparing ten mixer configurations under otherwise controlled formulation conditions, it shows why manually prepared or laminar-mixed particles may not predict materials produced with turbulent-flow equipment at manufacturing scale.
-
AC008406.3, Cuproptosis, and Docetaxel Sensitivity
2026-09-11
A 2026 study identifies the lncRNA AC008406.3 as a suppressor of cuproptosis that contributes to reduced docetaxel sensitivity in breast cancer cells. Integrating TCGA-BRCA analysis with gene perturbation, mechanistic readouts, and rescue experiments, the work suggests that AC008406.3 inhibition could make docetaxel treatment more effective, although further validation is needed in animal models and clinical samples.
-
Ridaforolimus: mTOR Precision Meets Senolytic Discovery
2026-09-11
Ridaforolimus (Deforolimus, MK-8669) provides a mechanistically precise way to interrogate mTOR signaling across cancer models while informing the next generation of senescence and senolytic research. This article connects pathway pharmacology, assay strategy, and machine-learning-enabled discovery without overstating current evidence.
-
Antimycin A4 for Reliable Cell Assays
2026-09-10
Learn how Antimycin A4, SKU C8711, can clarify inconsistent viability and metabolism data by combining ATP-citrate lyase inhibition with mitochondrial respiratory-chain modulation. This scenario-based guide covers assay design, storage, interpretation, and practical supplier selection.
-
Cy7 NHS Ester: Practical Labeling and QC Guide
2026-09-10
Cy7 NHS ester is a water-soluble, sulfonated near-infrared reagent for labeling accessible amino groups on proteins and peptides. It is suited to aqueous biomolecule conjugation and near-infrared fluorescent imaging, but live-cell or in vivo use still requires assay-specific controls for labeling degree, free-dye removal, signal stability, and biological compatibility.
-
Amphotericin B: Applied Research Workflows
2026-09-09
Build reproducible fungal membrane, biofilm, and immune-signaling assays around Amphotericin B while controlling solubility and cytotoxicity variables. This guide also translates recent ergosterol-potentiation findings into practical combination screens and troubleshooting decisions.
-
Cytosolic DNA and TDP-43 Homeostasis
2026-09-09
A 2024 Journal of Biological Chemistry study identifies cytosolic DNA accumulation as a regulator of TDP-43 condensation, nuclear depletion, and production of a short TDP-43 isoform. Its experimental framework connects DNA uptake, DNA damage, nuclear-envelope stress, and ALS-linked TDP-43 mutation to a common homeostatic mechanism that can inform future DNA damage response and neurodegeneration studies.
-
Oleanolic acid: Reliable Cell Assay Workflows
2026-09-08
A scenario-based guide to using Oleanolic acid (SKU N1826) in viability, proliferation, and dual-loaded liposome studies. It connects formulation controls, stock preparation, analytical separation, and vendor-selection criteria to more interpretable laboratory data.
-
Dacomitinib (PF-00299804) in Ferroptosis Research
2026-09-08
Dacomitinib (PF-00299804) enables durable ErbB pathway suppression in signaling, resistance, apoptosis, and cell-cycle assays. This workflow-focused guide shows how to combine pan-HER target engagement with the mitochondrial ferroptosis framework reported for METTL17, while distinguishing established evidence from exploratory applications.